NYSE: BHVN
Biohaven Ltd Stock Ownership - Who owns Biohaven?

Insider buying vs selling

Have Biohaven Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kimberly GentileSVP Clinical Operations2026-01-051,956$9.93
$19.42kSell
Matthew ButenChief Financial Officer2026-01-052,594$9.93
$25.76kSell
Bruce CarChief Scientific Officer2026-01-052,381$9.93
$23.64kSell
George C. ClarkVP Chief Accounting Officer2026-01-051,117$9.93
$11.09kSell
Vlad CoricChief Executive Officer2026-01-057,430$9.93
$73.78kSell
George C. ClarkVP Chief Accounting Officer2025-11-1717,000$8.52
$144.77kBuy
Gregory BaileyDirector2025-11-13400,000$7.50
$3.00MBuy
Vlad CoricChief Executive Officer2025-11-13333,333$7.50
$2.50MBuy
Vlad CoricChief Executive Officer2025-11-13333,333$7.50
$2.50MBuy
John W. ChildsDirector2025-11-133,333,333$7.50
$25.00MBuy

1 of 1

BHVN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BHVN insiders and whales buy or sell their stock.

BHVN Shareholders

What type of owners hold Biohaven Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John W. Childs10.35%15,564,580$170.90MInsider
Suvretta Capital Management LLC6.84%10,286,937$112.95MInstitution
Stifel Financial Corp6.61%9,939,856$109.14MInstitution
Stifel Financial Corp 16.61%9,939,856$109.14MInstitution
Blackrock Inc6.28%9,448,040$103.74MInstitution
Infinitum Asset Management LLC4.16%6,250,000$68.63MInstitution
State Street Corp3.80%5,716,487$62.77MInstitution
Vlad Coric3.72%5,590,131$61.38MInsider
Tcg Crossover Management LLC3.08%4,631,317$50.85MInstitution
Vanguard Group Inc2.92%4,395,946$48.27MInstitution

1 of 3

BHVN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BHVN78.77%15.74%Net Buying
NBTX11.78%0.00%
MBX44.52%55.48%Net BuyingNet Buying
DMRA1.84%27.36%Net Selling
IMCR95.91%4.09%Net SellingNet Selling

Biohaven Stock Ownership FAQ

Who owns Biohaven?

Biohaven (NYSE: BHVN) is owned by 78.77% institutional shareholders, 15.74% Biohaven insiders, and 5.49% retail investors. John W. Childs is the largest individual Biohaven shareholder, owning 15.56M shares representing 10.35% of the company. John W. Childs's Biohaven shares are currently valued at $170.90M.

If you're new to stock investing, here's how to buy Biohaven stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.